Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Porphyria
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug, Other
Participants:
56
Start Date:
August 2020
Efficacy of Based MRI Contrast Media Against Covid-19
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
159
Start Date:
June 1, 2020
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Combination Product, Procedure
Participants:
50
Start Date:
May 1, 2019
PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients: a Feasibility Study
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
94
Start Date:
November 16, 2017
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
49
Start Date:
September 6, 2017
Newer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects With Chronic Hepatitis C
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
17
Start Date:
October 2016
A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Clinical Activity of Subcutaneously Administered ALN-AS1 in Patients With Acute Intermittent Porphyria Who Have Completed a Previous Clinical Study With ALN-AS1
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Biological, Other
Participants:
20
Start Date:
October 30, 2015
Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria
Clinical Trial
Status:
Active, not recruiting
Participants:
136
Start Date:
August 2014
A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2
Intervention Type:
Other, Biological
Participants:
40
Start Date:
April 28, 2014
A Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria
Clinical Trial
Status:
Active, not recruiting
Intervention Type:
Drug
Participants:
50
Start Date:
April 28, 2014
Acute Porphyrias: Biomarkers for Disease Activity and Response to Treatment
Clinical Trial
Status:
Active, not recruiting
Participants:
100
Start Date:
July 2012
Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
Clinical Trial
Status:
Active, not recruiting
Participants:
150
Start Date:
November 2011
7202 Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)
Showing 1-12 of 14
Next